These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29137443)

  • 1. The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.
    Wang X; Su S; Guo Y
    Oncotarget; 2017 Oct; 8(48):84506-84514. PubMed ID: 29137443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
    Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
    Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review.
    Tan S; Zheng Q; Zhang W; Zhou M; Xia C; Feng W
    Front Immunol; 2024; 15():1408700. PubMed ID: 39050856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
    Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
    Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis.
    Gu L; Li H; Chen L; Ma X; Li X; Gao Y; Zhang Y; Xie Y; Zhang X
    Oncotarget; 2016 May; 7(22):31926-42. PubMed ID: 26942464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
    Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
    J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
    Peng H; Luo X
    Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis.
    Li W; Tao L; Zhang L; Xiu D
    Onco Targets Ther; 2017; 10():3391-3397. PubMed ID: 28744143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: A meta-analysis.
    Li M; Deng Q; Zhang L; He S; Rong J; Zheng F
    Pathol Res Pract; 2019 Jan; 215(1):5-11. PubMed ID: 30401580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis.
    Peng LP; Li J; Li XF
    World J Clin Cases; 2022 Mar; 10(7):2194-2205. PubMed ID: 35321179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis.
    Wang X; Ni X; Tang G
    Front Oncol; 2019; 9():757. PubMed ID: 31475109
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
    Ma JY; Liu Q
    Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer.
    Wang J; Liu Y; Zhang N; Li X; Xin P; Bi J; Kong C
    Oncotarget; 2017 Sep; 8(41):70874-70882. PubMed ID: 29050328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
    Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
    Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Hematological Markers for Patients with Nasopharyngeal Carcinoma: A Meta-analysis.
    Yang S; Zhao K; Ding X; Jiang H; Lu H
    J Cancer; 2019; 10(11):2568-2577. PubMed ID: 31258763
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients.
    Lin S; Fang Y; Mo Z; Lin Y; Ji C; Jian Z
    World J Surg Oncol; 2020 Jul; 18(1):186. PubMed ID: 32711514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
    Li DZ; Guo J; Song QK; Hu XJ; Bao XL; Lu J
    Transl Cancer Res; 2022 Nov; 11(11):4037-4050. PubMed ID: 36523315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
    Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
    Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.